Alzheimer’s Disease Cerebrospinal Fluid
Alzheimer’s Disease Cerebrospinal Fluid (CSF) supports research into amyloid-beta, tau pathology, and neurodegenerative biomarkers.
| Lot # | Condition | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|
| 77999 | Alzheimer's Disease | 47 | Male | Turkey |
Levotiron 25 mg once daily
|
1 | $1,600.00 | ||
| 77980 | Alzheimer's Disease | 62 | Female | Turkey |
Diltizem 90 mg once daily,
|
1 | $1,600.00 | ||
| 77981 | Alzheimer's Disease | 76 | Male | Turkey |
Janumet 1000 mg once daily
|
1 | $1,600.00 | ||
| 77982 | Alzheimer's Disease | 57 | Female | Turkey |
Benipin 10 mg once daily,Glifor 1000 mg once daily
|
1 | $1,600.00 | ||
| 77983 | Alzheimer's Disease | 67 | Male | Turkey |
Ventolin 100 mcg once daily
|
1 | $1,600.00 | ||
| 78003 | Alzheimer's Disease | 75 | Female | Turkey |
Delix 2.5 mg once daily
|
1 | $1,600.00 | ||
| 78004 | Alzheimer's Disease | 51 | Female | Turkey |
Tarka 180/2 mg once daily
|
1 | $1,600.00 | ||
| 77985 | Alzheimer's Disease | 60 | Male | Turkey |
Tarka 180/2 mg once daily
|
1 | $1,600.00 | ||
| 77986 | Alzheimer's Disease | 57 | Male | Turkey |
Levotiron 100 mg once daily,
|
1 | $1,600.00 | ||
| 78005 | Alzheimer's Disease | 65 | Female | Turkey |
Levotiron 100 mg once daily, Delix 2.5 mg once daily
|
1 | $1,600.00 |
Alzheimer’s Disease Cerebrospinal Fluid (CSF)
CSF samples for amyloid-beta, tau, and neurodegenerative biomarker research
Alzheimer’s disease cerebrospinal fluid (CSF) is a gold-standard biofluid for studying hallmark biomarkers such as amyloid-beta (Aβ) and tau proteins. These CSF samples provide direct insight into neurodegenerative processes and are widely used in biomarker discovery and therapeutic development.
Product Features
- Collected from clinically diagnosed Alzheimer’s disease donors in Turkey
- Collected via lumbar puncture under IRB-approved protocols
- Annotated with demographic data and infectious disease testing
Applications
- Amyloid and tau biomarker analysis
- Disease progression and staging studies
- Drug development and target validation
- Neurodegenerative pathway research
Quality & Compliance
- IRB-approved collection protocols
- Standardized processing and QC
- Ensured protein integrity and stability
Ordering Information
Available as in-stock CSF samples. For orders outside of the United States or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability.
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – all our products are research use only (RUO).
1 Answer
You can find our full product catalog here.
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: Quality and Compliance
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Cerebrospinal Fluid cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.